全文获取类型
收费全文 | 19749篇 |
免费 | 1867篇 |
国内免费 | 354篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 391篇 |
妇产科学 | 98篇 |
基础医学 | 2780篇 |
口腔科学 | 237篇 |
临床医学 | 1698篇 |
内科学 | 4907篇 |
皮肤病学 | 348篇 |
神经病学 | 192篇 |
特种医学 | 391篇 |
外国民族医学 | 6篇 |
外科学 | 2265篇 |
综合类 | 2342篇 |
现状与发展 | 3篇 |
预防医学 | 673篇 |
眼科学 | 119篇 |
药学 | 2209篇 |
9篇 | |
中国医学 | 1874篇 |
肿瘤学 | 1374篇 |
出版年
2024年 | 25篇 |
2023年 | 460篇 |
2022年 | 576篇 |
2021年 | 834篇 |
2020年 | 913篇 |
2019年 | 875篇 |
2018年 | 858篇 |
2017年 | 886篇 |
2016年 | 807篇 |
2015年 | 689篇 |
2014年 | 1276篇 |
2013年 | 2374篇 |
2012年 | 986篇 |
2011年 | 1070篇 |
2010年 | 804篇 |
2009年 | 927篇 |
2008年 | 859篇 |
2007年 | 907篇 |
2006年 | 772篇 |
2005年 | 629篇 |
2004年 | 561篇 |
2003年 | 401篇 |
2002年 | 392篇 |
2001年 | 338篇 |
2000年 | 316篇 |
1999年 | 290篇 |
1998年 | 282篇 |
1997年 | 204篇 |
1996年 | 173篇 |
1995年 | 163篇 |
1994年 | 149篇 |
1993年 | 136篇 |
1992年 | 125篇 |
1991年 | 94篇 |
1990年 | 93篇 |
1989年 | 74篇 |
1988年 | 62篇 |
1987年 | 66篇 |
1986年 | 68篇 |
1985年 | 71篇 |
1984年 | 73篇 |
1983年 | 51篇 |
1982年 | 71篇 |
1981年 | 56篇 |
1980年 | 35篇 |
1979年 | 27篇 |
1978年 | 22篇 |
1977年 | 17篇 |
1976年 | 12篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
1.
2.
3.
《Journal of infection and chemotherapy》2022,28(4):587-590
A 37-year-old man developed right ankle pain and swelling six days after being diagnosed with coronavirus disease (COVID-19). Despite conservative treatment, his ankle symptoms persisted. Magnetic resonance imaging and computed tomography showed synovial hypertrophy and bone erosion in the ankle. Following arthroscopic synovectomy, performed 69 days after the COVID-19 diagnosis, the pain improved significantly. The clinical course was consistent with that of reactive arthritis following severe acute respiratory syndrome coronavirus 2 infection. The pathological findings resembled rheumatoid nodules. The bone erosion may have originated from the inflammatory pathway, which resembles the mechanism of rheumatoid arthritis. 相似文献
4.
Tofacitinib is an immunosuppressive and disease-modifying therapy in rheumatoid arthritis. It may result in many infections flaring up. It is important to take precautions of all kinds (cardiovascular, malignancy, infections etc.) before starting tofacitinib. In this article, we have highlighted important steps where we need to take precautions before starting tofacitinib. 相似文献
5.
6.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献7.
8.
9.
10.
Peng Li Sha-Sha Tao Meng-Qin Zhao Jun Li Xiu Wang Hai-Feng Pan 《Immunological investigations》2015,44(7):603-615
Objective: Association of matrix metalloproteinases (MMPs) gene polymorphisms with rheumatoid arthritis is controversial. We conduct a meta-analysis to clarify this dispute.Methods: We systematically searched the electronic PUBMED, EMBASE and CNKI databases for research articles about MMPs (MMP-1, MMP-2, MMP-3, MMP-9) gene polymorphisms and rheumatoid arthritis (RA) up to January 2015. According to the heterogeneity, fixed-effects or random-effects models were used to calculate crude odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: A total of 11 articles involving 2143 cases and 2049 controls were included in this meta-analysis. Overall, no significant associations were observed between MMP-1-1607 1G/2G polymorphism and RA. Stratification by ethnicity, no significant associations were observed in Caucasian populations. Similarly, no significant associations were observed between MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms and RA in overall and Caucasian populations, respectively. However, a weak association was found between MMP-2-1306 C/T polymorphism and RA (C vs. T, OR?=?0.813, 95%CI?=?0.694–0.953, p?=?0.010) in overall populations.Conclusions: The present meta-analysis suggests that MMP-1-1607 1G/2G, MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms are not associated with the susceptibility of RA, but MMP-2 -1306 C/T is weakly associated with susceptibility to RA. Further studies with more sample size are needed for definitive conclusions. 相似文献